IFNA1 and hepatocellular carcinoma: This study highlighted that the decrease in LSV was significantly larger in the DAA group than in the peg-IFN group at both 48 weeks and 96 weeks, but the HCC incidence was not significantly different between the DAA and peg-IFN groups (5.5% vs. 5.4%) at 144 weeks.